Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination

被引:7
|
作者
Pasqualetti, Francesco [1 ,2 ]
Zanotti, Sofia [3 ]
机构
[1] Univ Oxford, Dept Oncol, Oxford OX3 7DQ, England
[2] Azienda Osped Univ Pisana, Radiat Oncol, Pisa, Italy
[3] IRCCS Humanitas Univ Res Hosp, Anat Pathol Unit, Milan, Italy
关键词
D O I
10.1038/s41416-023-02194-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, Liau et al. reported the results of Phase 3 clinical trial testing DCVax-L vaccines on patients with glioblastoma. Despite the promising and significant results obtained, the study design and the long-lasting period of recruitment of this work deserve some reflection.
引用
收藏
页码:895 / 896
页数:2
相关论文
共 50 条
  • [31] An Autologous Tumor Lysate Dendritic Cell Vaccine Is Most Effective in Recurrent, Advanced-Stage Melanoma in a Randomized Controlled Trial
    O'Shea, Anne
    Chick, Robert C.
    Adams, Alexandra
    McCarthy, Patrick
    Bohan, Phillip Kemp
    Vreeland, Timothy J.
    Clifton, Guy T.
    Peoples, George E., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S242 - S242
  • [32] Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma.
    Ridolfi, Laura
    Gurrieri, Lorena
    Riva, Nada
    Bulgarelli, Jenny
    De Rosa, Francesco
    Guidoboni, Massimo
    Fausti, Valentina
    Ranallo, Nicoletta
    Tazzari, Marcella
    Petrini, Massimiliano
    Granato, Anna Maria
    Pancisi, Elena
    Foca, Flavia
    Dall'Agata, Monia
    Amadori, Elena
    Cortesi, Pietro
    Gamboni, Alessandro
    Pasini, Giuseppe
    Ibrahim, Toni
    Tosatto, Luigino
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Treatment with tumor lysate-pulsed autologous dendritic cells prolongs survival in patients with recurrent glioblastoma multiforme
    Bosch, Marnix
    Prins, Robert
    Liau, Linda
    CANCER RESEARCH, 2015, 75
  • [34] Safety and efficacy of autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccination in combination with systemic therapies in patients with metastatic melanoma
    Chick, Robert Connor
    Hickerson, Annelies T.
    Clifton, Guy Travis
    Bohan, Phillip M. Kemp
    Brown, Tommy A.
    Cindass, Jessica L.
    Myers, John W.
    Vreeland, Timothy J.
    Jackson, Doreen O.
    Hale, Diane F.
    Peace, Kaitlin M.
    Herbert, Garth S.
    Yu, Xianzhong
    Wagner, Thomas
    Peoples, George E.
    CANCER RESEARCH, 2020, 80 (16)
  • [35] Early trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in ovarian cancer patients
    Peace, Kaitlin M.
    Vreeland, Timothy J.
    Clifton, Guy T.
    Hale, Diane F.
    Jackson, Doreen O.
    Berry, John S.
    Trappey, Alfred F.
    Herbert, Garth S.
    Hardin, Mark O.
    Nichol, Pauline T.
    Yin, Sook L.
    Yu, Xianzhong
    Wagner, Thomas E.
    Peoples, George E.
    CANCER RESEARCH, 2017, 77
  • [36] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Hunn, Martin K.
    Bauer, Evelyn
    Wood, Catherine E.
    Gasser, Olivier
    Dzhelali, Marina
    Ancelet, Lindsay R.
    Mester, Brigitta
    Sharples, Katrina J.
    Findlay, Michael P.
    Hamilton, David A.
    Hermans, Ian F.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 319 - 329
  • [37] Clinical efficacy of vaccination with the autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccine in metastatic melanoma.
    Hickerson, Annelies
    Clifton, Guy T.
    Brown, Tommy A.
    Campf, Jessica
    Myers, John William
    Vreeland, Timothy J.
    Hale, Diane F.
    Peace, Kaitlin M.
    Jackson, Doreen O.
    Yu, Xianzhong
    Wagner, Thomas
    Peoples, George Earl
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Martin K. Hunn
    Evelyn Bauer
    Catherine E. Wood
    Olivier Gasser
    Marina Dzhelali
    Lindsay R. Ancelet
    Brigitta Mester
    Katrina J. Sharples
    Michael P. Findlay
    David A. Hamilton
    Ian F. Hermans
    Journal of Neuro-Oncology, 2015, 121 : 319 - 329
  • [39] T CELL RESPONSE DYNAMICS IN PHASE 3 GLIOBLASTOMA PATIENTS IMMUNIZED WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH AUTOLOGOUS TUMOR CELL LYSATE
    Bosch, Marnix
    Liau, Linda
    Ashkan, Keyoumars
    NEURO-ONCOLOGY, 2023, 25
  • [40] Vaccination with autologous dendritic cells pulsed with allogeneic tumour lysate in patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Engell-Norregard, L.
    Kvistborg, P.
    Zocca, M. B.
    Mellemgaard, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 516 - 517